An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. NEJM. July 14th, 2020

Spread the word

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion SARS-CoV-2 spike protein. For more information, please click here